• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTBX:US

18.45 USD 0.70 3.94%

As of 09:29:30 ET on 07/23/2014.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTBX)

Year To Date: +9.17% 3-Month: +10.02% 3-Year: +32.72% 52-Week Range: 14.46 - 20.95
1-Month: +0.87% 1-Year: +22.26% 5-Year: +25.53% Beta vs MXWO: 1.07

Mutual Fund Chart for FBTBX

No chart data available.
  • FBTBX:US 18.45
  • 1M
  • 1Y
Interactive FBTBX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTBX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTBX

NAV (on 2014-07-23) 18.45
Assets (M) (on 2014-06-30) 1,557.46
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTBX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2013-12-13) 0.05
Dividend Yield (ttm) 0.28

Fees & Expenses for FBTBX

Front Load 0.00
Back Load 5.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 1.00
Expense Ratio 1.94

Top Fund Holdings for FBTBX

Filing Date: 05/31/2014
Name Position Value % of Total
Gilead Sciences Inc 2,917,085 236,896,473 16.526%
Amgen Inc 1,044,168 121,113,046 8.449%
Biogen Idec Inc 328,356 104,867,056 7.316%
Celgene Corp 808,646 61,873,549 4.316%
Alexion Pharmaceuticals Inc 339,134 56,404,767 3.935%
Regeneron Pharmaceuticals Inc 167,478 51,409,047 3.586%
Vertex Pharmaceuticals Inc 652,089 47,119,951 3.287%
Intercept Pharmaceuticals Inc 168,060 39,764,677 2.774%
InterMune Inc 803,965 31,853,093 2.222%
BioMarin Pharmaceutical Inc 438,438 25,411,866 1.773%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil